![Cécile Nguyen-Cluzel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cécile Nguyen-Cluzel
Directeur/Bestuurslid bij OSE IMMUNOTHERAPEUTICS
Oorsprong van het eerstegraads netwerk van Cécile Nguyen-Cluzel
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
MBO+ SAS
![]() MBO+ SAS Investment ManagersFinance Mbo & Co. Sas is an Independent Private Equity firm founded in 2002. Mbo & Co. Sas is headquartered in Paris.
32
| Private Company | Investment Managers | 32 |
Public Company | Pharmaceuticals: Major | 16 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Cécile Nguyen-Cluzel via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
CFDP Assurances SA
![]() CFDP Assurances SA Insurance Brokers/ServicesFinance CFDP Assurances SA operates as an insurance provider. It also specializes in legal risk and protection management. The company was founded in 1945 and is headquartered in Lyon, France. | Insurance Brokers/Services | Director/Board Member Director/Board Member Director/Board Member | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
Axio Capital SAS | Investment Managers | Founder Founder Private Equity Analyst | |
3i Gestion SA
![]() 3i Gestion SA Investment ManagersFinance 3i Gestion SA (3i Gestion) is the French. The firm was established in 1983 and is a pioneer in the French private equity and venture capital industry. 3i Gestion SA is headquartered in Paris. | Investment Managers | Private Equity Investor Private Equity Investor | |
ESSEC Business School | College/University | Masters Business Admin Masters Business Admin | |
PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member Chairman | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Horama SA
![]() Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Noukies SA
![]() Noukies SA Specialty StoresRetail Trade Noukies SA retails soft toys, night wear, day wear, beach wear, furniture and baby items. Its products include daisy and coco, iris and babette, lala, Louis and scott, mix and match soft toys, boys and girls night and day wear, beach wear, furniture and baby items. The company was founded by Katia Gillot-de Paepe and Simon-Pierre Gillot-de Paepe in1996 and is headquartered in Tubize, Belgium. | Specialty Stores | Director/Board Member Director/Board Member | |
Atalante SAS
![]() Atalante SAS Investment ManagersFinance Atalante SAS (CAPZA) is a private equity firm founded in 2004 by Thierry DeGroote, David Hoppenot and Christophe Karvelis Senn. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Analyst Private Equity Investor | |
Ecole des Ingenieurs | College/University | Undergraduate Degree | |
Open SAS
![]() Open SAS Miscellaneous Commercial ServicesCommercial Services Part of Groupe Open SAS, Open provides IT infrastructure and software consultancy services. The company is based in Paris, France. The French company was founded in 1993. The CEO is Valérie Benvenuto. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
3i Private Equity /France/ | Investment Managers | Private Equity Analyst | |
Tc Land Expression SA
![]() Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Chief Operating Officer | |
Strategic Ventures & Research, Inc. | Founder | ||
Morgan Stanley Real Estate
![]() Morgan Stanley Real Estate Investment ManagersFinance Founded in 1969, Morgan Stanley Real Estate is a real estate franchise located in New York City. The firm is a subsidiary of Morgan Stanley. (NYSE: MS). | Investment Managers | Corporate Officer/Principal | |
SECURINFOR SOCIÉTÉ ANONYME | Information Technology Services | Director/Board Member | |
Valtech Axelboss SAS
![]() Valtech Axelboss SAS Information Technology ServicesTechnology Services Part of Sia Partners SASU, Valtech Axelboss SAS provides computer and technology management consulting services. The company is based in Paris, France. Valtech Axelboss was acquired by Sia Partners SASU from Valtech SA on November 05, 2010. | Information Technology Services | Corporate Officer/Principal | |
Big Booster'S
![]() Big Booster'S Miscellaneous Commercial ServicesCommercial Services Big Booster's is an international accelerator that focuses on positive impact. The French company has accelerated 278 startups to date. The private company was founded by Didier Hoch and has four years of experience in accelerating startups. | Miscellaneous Commercial Services | Founder | |
Groupe Ouroumoff SARL
![]() Groupe Ouroumoff SARL Air Freight/CouriersTransportation Groupe Ouroumoff SARL operates as a holding company with interests in logistics. The company is headquartered in Paris, France. | Air Freight/Couriers | Chairman | |
FOLLIS SAS
![]() FOLLIS SAS Investment ManagersFinance Perfectis Private Equity SA (Perfectis) is a leading independent French private equity firm which was founded in 2000 by Gabriel Fossorier and Jean-Marie Lavirotte. Located in Paris, Perfectis provides equity financing to unlisted companies in the French lower mid-market, with commitments from international funds of funds, insurance companies and banks. The firm's relationship with their cornerstone investor, Euler Hermes, provides Perfectis with a unique source of proprietary economic information. | Investment Managers | Private Equity Analyst | |
Goliver Therapeutics | Director/Board Member | ||
France Biotech Association
![]() France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Chairman | |
Sanofi Pasteur
![]() Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | Chairman | |
Fondation pour l’Université de Lyon | Chairman | ||
Fondation Universite Grenoble Alpes | Director/Board Member | ||
Underground Charity Foundation | Chairman | ||
Aventis Pharma International SAS | Corporate Officer/Principal | ||
Germitec SA
![]() Germitec SA Medical SpecialtiesHealth Technology Germitec SA engages in the research, design, and marketing of medical hygiene systems. It develops Antigermix, which is used in disinfecting heat-sensitive medical instruments. The company was founded in 2005 and is headquartered in Ivry-sur-Seine, France. | Medical Specialties | Director/Board Member | |
European Vaccine Manufacturers | President | ||
Mouvement des Entreprises de France
![]() Mouvement des Entreprises de France Miscellaneous Commercial ServicesCommercial Services Mouvement des Entreprises de France operates a network for entrepreneurs. The non-profit company is based in Paris, France. The CEO of the French company is Philippe Pascal Rene Gautier. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Framatome SAS
![]() Framatome SAS Electrical ProductsProducer Manufacturing Framatome SAS engages in the construction, operations, and maintenance of nuclear reactors. It offers heavy primary loop components, mobile component for nuclear facilities, nuclear engineering, nuclear maintenance, fabrication of fuel assemblies for reactors, and instrumentation and control services. The company was founded in 1958 and is headquartered in Courbevoie, France. | Electrical Products | Corporate Officer/Principal | |
Apave SA
![]() Apave SA Miscellaneous Commercial ServicesCommercial Services Apave SA specializes in tests for quality control. The company was founded in 1867 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Atlanpole Biotherapies
![]() Atlanpole Biotherapies Miscellaneous Commercial ServicesCommercial Services Atlanpole Biotherapies provides immunotherapy, regenerative medicine, and radio pharmacy bio cluster services. The company is based in Nantes, France. | Miscellaneous Commercial Services | Director/Board Member | |
École Polytechnique Fédérale de Lausanne | College/University | Graduate Degree | |
Eye Tech Care SA
![]() Eye Tech Care SA Medical SpecialtiesHealth Technology Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France. | Medical Specialties | Director/Board Member | |
Apera Capital(France) | Investment Managers | Private Equity Investor | |
Centre d'Etudes Supérieures de Techniques Industrielles | College/University | Undergraduate Degree | |
University of Nantes | College/University | Graduate Degree | |
Louis Pasteur University | College/University | Graduate Degree | |
Amal Therapeutics SA
![]() Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Biotechnology | Chief Operating Officer | |
Swiss Healthcare Licensing Group | Director/Board Member | ||
Themis Bioscience GmbH
![]() Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
Tridek-One Therapeutics SAS
![]() Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Miscellaneous Commercial Services | Chief Executive Officer | |
University of Pavia | College/University | Doctorate Degree |
Statistieken
Internationaal
Frankrijk | 41 |
Zwitserland | 4 |
België | 3 |
Verenigde Staten | 3 |
Nederland | 2 |
Sectoraal
Health Technology | 13 |
Finance | 9 |
Consumer Services | 9 |
Commercial Services | 9 |
Technology Services | 3 |
Operationeel
Director/Board Member | 73 |
Private Equity Investor | 36 |
Corporate Officer/Principal | 36 |
Chairman | 25 |
Chief Executive Officer | 20 |
Sterkste connecties
- Beurs
- Insiders
- Cécile Nguyen-Cluzel
- Bedrijfsconnecties